Filter your results
- 1
- 1
- 2
- 2
- 1
- 1
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
A candidate gene study identifies a haplotype of CD2 as novel susceptibility factor for systemic sclerosisClinical and experimental rheumatology, 2016, 34 (5), pp.S43-S48
Journal articles
hal-01606686v1
|
|||
|
Acazicolcept (ALPN-101), a dual ICOS/CD28 antagonist, demonstrates efficacy in systemic sclerosis preclinical mouse modelsArthritis Research and Therapy, 2022, ⟨10.1186/s13075-021-02709-2⟩
Journal articles
hal-03844870v1
|